Shuifu Tang

Statistics

Publications

Citations

543

H-Index

Active since

2019

Affiliations

First Affiliated Hospital of Guangzhou University of Chinese Medicine(Current)

University of Chicago

Bayer (Germany)

Guangzhou University of Chinese Medicine

Richard L. Roudebush VA Medical Center

Shuifu Tang is an author at First Affiliated Hospital of Guangzhou University of Chinese Medicine specializing in renal pharmacology, renal disease, and chronic kidney disease.

ORCID

Publications per year

2019–2024

Publications

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Hiddo J.L. Heerspink, Rajiv Agarwal, George L. Bakris et al. · Nephrology Dialysis Transplantation · 2024 · 77 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway

Haitao Tu, Duanhua Ma, Yuanyuan Luo et al. · Bioengineered · 2021 · 73 citations · Full text

Medicine, Nephrology, Pharmacology +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

1–5 of 9